Aperio Group’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$149K Sell
2020
Q3
$271K Buy
2020
Q2
$234K Buy
2020
Q1
$51K Buy
2019
Q4
Sell
2019
Q3
$30K Sell
2019
Q2
$88K Buy
2018
Q4
Sell
2018
Q3
$146K Buy